LTRN
Lantern Pharma·NASDAQ
--
--(--)
--
--(--)
2.31 / 10
Underperform
Lantern Pharma's fundamental profile is weak (score 2.3/10). Key concerns include low Profit-MV (0.47) and Net income-Revenue (-0.15) differences, while Asset-MV (-0.51) and Revenue-MV (-0.26) are also suboptimal. Although Cash-MV (-0.07) and high Inventory turnover (47.88) provide some relief, the overall composition warrants a selective stance due to limited growth and valuation risks.
Analysis Checks(6/10)
Revenue-MV
Value-0.26
Score1/3
Weight12.47%
1M Return5.63%
Value-0.26
Score1/3
Weight12.47%
1M Return5.63%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.36%
1M Return0.22%
Value36.70
Score1/3
Weight0.36%
1M Return0.22%
Net income-Revenue
Value-0.15
Score2/3
Weight17.69%
1M Return8.04%
Value-0.15
Score2/3
Weight17.69%
1M Return8.04%
Current assets turnover ratio
Value1.78
Score2/3
Weight3.09%
1M Return1.75%
Value1.78
Score2/3
Weight3.09%
1M Return1.75%
Asset-MV
Value-0.51
Score0/3
Weight8.63%
1M Return4.17%
Value-0.51
Score0/3
Weight8.63%
1M Return4.17%
Inventory turnover ratio
Value47.88
Score3/3
Weight11.42%
1M Return5.89%
Value47.88
Score3/3
Weight11.42%
1M Return5.89%
Profit-MV
Value0.47
Score2/3
Weight17.45%
1M Return7.95%
Value0.47
Score2/3
Weight17.45%
1M Return7.95%
PB-ROE
Value2.39
Score0/3
Weight8.95%
1M Return4.05%
Value2.39
Score0/3
Weight8.95%
1M Return4.05%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.64%
1M Return1.53%
Value7993.84
Score3/3
Weight2.64%
1M Return1.53%
Cash-MV
Value-0.07
Score2/3
Weight17.29%
1M Return7.78%
Value-0.07
Score2/3
Weight17.29%
1M Return7.78%
Revenue-MV
Value-0.26
Score1/3
Weight12.47%
1M Return5.63%
Value-0.26
Score1/3
Weight12.47%
1M Return5.63%
Inventory turnover ratio
Value47.88
Score3/3
Weight11.42%
1M Return5.89%
Value47.88
Score3/3
Weight11.42%
1M Return5.89%
Gross profit margin (%)
Value36.70
Score1/3
Weight0.36%
1M Return0.22%
Value36.70
Score1/3
Weight0.36%
1M Return0.22%
Profit-MV
Value0.47
Score2/3
Weight17.45%
1M Return7.95%
Value0.47
Score2/3
Weight17.45%
1M Return7.95%
Net income-Revenue
Value-0.15
Score2/3
Weight17.69%
1M Return8.04%
Value-0.15
Score2/3
Weight17.69%
1M Return8.04%
PB-ROE
Value2.39
Score0/3
Weight8.95%
1M Return4.05%
Value2.39
Score0/3
Weight8.95%
1M Return4.05%
Current assets turnover ratio
Value1.78
Score2/3
Weight3.09%
1M Return1.75%
Value1.78
Score2/3
Weight3.09%
1M Return1.75%
Fixed assets turnover ratio
Value7993.84
Score3/3
Weight2.64%
1M Return1.53%
Value7993.84
Score3/3
Weight2.64%
1M Return1.53%
Asset-MV
Value-0.51
Score0/3
Weight8.63%
1M Return4.17%
Value-0.51
Score0/3
Weight8.63%
1M Return4.17%
Cash-MV
Value-0.07
Score2/3
Weight17.29%
1M Return7.78%
Value-0.07
Score2/3
Weight17.29%
1M Return7.78%
Is LTRN undervalued or overvalued?
- LTRN scores 2.31/10 on fundamentals and holds a Premium valuation at present. Backed by its -84.78% ROE, 0.00% net margin, -1.56 P/E ratio, 3.08 P/B ratio, and 1.69% earnings growth, these metrics solidify its Underperform investment rating.
